These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10501248)

  • 1. Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience.
    Pittman PR; Liu CT; Cannon TL; Makuch RS; Mangiafico JA; Gibbs PH; Peters CJ
    Vaccine; 1999 Aug; 18(1-2):181-9. PubMed ID: 10501248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine.
    Pittman PR; Makuch RS; Mangiafico JA; Cannon TL; Gibbs PH; Peters CJ
    Vaccine; 1996 Mar; 14(4):337-43. PubMed ID: 8744562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study.
    Rusnak JM; Gibbs P; Boudreau E; Clizbe DP; Pittman P
    Vaccine; 2011 Apr; 29(17):3222-9. PubMed ID: 21354483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates.
    Pittman PR; Norris SL; Brown ES; Ranadive MV; Schibly BA; Bettinger GE; Lokugamage N; Korman L; Morrill JC; Peters CJ
    Vaccine; 2016 Jan; 34(4):523-530. PubMed ID: 26706271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans.
    Pittman PR; McClain D; Quinn X; Coonan KM; Mangiafico J; Makuch RS; Morrill J; Peters CJ
    Vaccine; 2016 Jan; 34(4):424-429. PubMed ID: 26718688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of laboratory staff to vaccination with an inactivated Rift Valley fever vaccine--TSI-GSD 200.
    Frank-Peterside N
    Afr J Med Med Sci; 2000 Jun; 29(2):89-92. PubMed ID: 11379456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids.
    Morrill JC; Mebus CA; Peters CJ
    Am J Vet Res; 1997 Oct; 58(10):1110-4. PubMed ID: 9328663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves.
    Morrill JC; Laughlin RC; Lokugamage N; Wu J; Pugh R; Kanani P; Adams LG; Makino S; Peters CJ
    Vaccine; 2013 Oct; 31(43):4988-94. PubMed ID: 23994375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rift Valley fever vaccine trial. I. Side effects and serologic response over a six-month follow-up.
    Kark JD; Aynor Y; Peters CJ
    Am J Epidemiol; 1982 Nov; 116(5):808-20. PubMed ID: 6890766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania.
    Nyundo S; Adamson E; Rowland J; Palermo PM; Matiko M; Bettinger GE; Wambura P; Morrill JC; Watts DM
    Onderstepoort J Vet Res; 2019 Jan; 86(1):e1-e8. PubMed ID: 30843406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Rift Valley fever vaccine trial: 2. Serological response to booster doses with a comparison of intradermal versus subcutaneous injection.
    Kark JD; Aynor Y; Peters CJ
    Vaccine; 1985 Jun; 3(2):117-22. PubMed ID: 4036270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rift Valley fever vaccine--antibody and immune response in cattle to a live and an inactivated vaccine.
    Barnard BJ
    J S Afr Vet Assoc; 1979 Sep; 50(3):155-7. PubMed ID: 551199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle.
    Morrill JC; Mebus CA; Peters CJ
    Am J Vet Res; 1997 Oct; 58(10):1104-9. PubMed ID: 9328662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of lamb and calf responses to Rift Valley fever MP-12 vaccination.
    Wilson WC; Bawa B; Drolet BS; Lehiy C; Faburay B; Jasperson DC; Reister L; Gaudreault NN; Carlson J; Ma W; Morozov I; McVey DS; Richt JA
    Vet Microbiol; 2014 Aug; 172(1-2):44-50. PubMed ID: 24856133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of an inactivated eastern equine encephalitis virus vaccine.
    Pierson BC; Cardile AP; Okwesili AC; Downs IL; Reisler RB; Boudreau EF; Kortepeter MG; Koca CD; Ranadive MV; Petitt PL; Kanesa-Thasan N; Rivard RG; Liggett DL; Haller JM; Norris SL; Purcell BK; Pittman PR; Saunders DL; Keshtkar Jahromi M
    Vaccine; 2021 May; 39(20):2780-2790. PubMed ID: 33888325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent rift valley fever virus.
    Morrill JC; Peters CJ
    J Infect Dis; 2011 Jul; 204(2):229-36. PubMed ID: 21673033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of a formalin-inactivated Rift Valley fever vaccine: evaluation of a vaccination campaign for cattle in Mozambique.
    Lagerqvist N; Moiane B; Bucht G; Fafetine J; Paweska JT; Lundkvist A; Falk KI
    Vaccine; 2012 Oct; 30(46):6534-40. PubMed ID: 22947138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
    Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled field trial to assess the immunogenicity and safety of rift valley fever clone 13 vaccine in livestock.
    Njenga MK; Njagi L; Thumbi SM; Kahariri S; Githinji J; Omondi E; Baden A; Murithi M; Paweska J; Ithondeka PM; Ngeiywa KJ; Dungu B; Donadeu M; Munyua PM
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003550. PubMed ID: 25756501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves.
    von Teichman B; Engelbrecht A; Zulu G; Dungu B; Pardini A; Bouloy M
    Vaccine; 2011 Aug; 29(34):5771-7. PubMed ID: 21664400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.